The central role of invasive functional coronary assessment for patients with ischemic heart disease.
暂无分享,去创建一个
G. Niccoli | C. Indolfi | M. Mancone | R. Pedrinelli | D. Morrone | S. De Rosa | R. Montone | A. Polimeni | A. Aimo | S. Muscoli | Alberto Aimo
[1] G. Niccoli,et al. Coronary provocative tests in the catheterization laboratory: Pathophysiological bases, methodological considerations and clinical implications. , 2020, Atherosclerosis.
[2] H. Thiele,et al. The 'Ten Commandments' for the 2020 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation. , 2020, European heart journal.
[3] F. Crea,et al. Assessment of Vascular Dysfunction in Patients Without Obstructive Coronary Artery Disease , 2020, JACC. Cardiovascular interventions.
[4] G. Niccoli,et al. Management of non-culprit coronary plaques in patients with acute coronary syndrome. , 2020, European heart journal.
[5] C. Berry,et al. Angina: contemporary diagnosis and management , 2020, Heart.
[6] Christopher J. Rush,et al. 1-Year Outcomes of Angina Management Guided by Invasive Coronary Function Testing (CorMicA) , 2019, JACC. Cardiovascular interventions.
[7] S. Miyata,et al. Coronary Functional Abnormalities in Patients With Angina and Nonobstructive Coronary Artery Disease. , 2019, Journal of the American College of Cardiology.
[8] F. Crea,et al. Clinical outcomes in patients with primary stable microvascular angina: is the Jury still out? , 2019, European heart journal. Quality of care & clinical outcomes.
[9] C. Berry,et al. Diastolic pressure ratio: new approach and validation vs. the instantaneous wave-free ratio. , 2019, European heart journal.
[10] C. Berry,et al. Diagnosis of patients with angina and non-obstructive coronary disease in the catheter laboratory , 2019, Heart.
[11] H. Thiele,et al. Optimized Treatment of ST-Elevation Myocardial Infarction. , 2019, Circulation research.
[12] K. Choi,et al. Physiological and Clinical Assessment of Resting Physiological Indexes: Resting Full-Cycle Ratio, Diastolic Pressure Ratio, and Instantaneous Wave-Free Ratio , 2019, Circulation.
[13] Volkmar Falk,et al. 2018 ESC/EACTS Guidelines on myocardial revascularization. , 2018, European heart journal.
[14] G. Niccoli,et al. Myocardial infarction with non-obstructive coronary arteries: dealing with pears and apples , 2019 .
[15] Christopher J. Rush,et al. Stratified Medical Therapy Using Invasive Coronary Function Testing in Angina: The CorMicA Trial. , 2018, Journal of the American College of Cardiology.
[16] B. Gersh,et al. Reappraisal of Ischemic Heart Disease: Fundamental Role of Coronary Microvascular Dysfunction in the Pathogenesis of Angina Pectoris , 2018, Circulation.
[17] F. D’Ascenzo,et al. Network meta‐analysis comparing iFR versus FFR versus coronary angiography to drive coronary revascularization , 2018, Journal of interventional cardiology.
[18] P. Jüni,et al. Five‐Year Outcomes with PCI Guided by Fractional Flow Reserve , 2018, The New England journal of medicine.
[19] A. Arai,et al. Cardiovascular Magnetic Resonance in Acute ST-Segment–Elevation Myocardial Infarction: Recent Advances, Controversies, and Future Directions , 2018, Circulation.
[20] C. Indolfi,et al. Pre-Angioplasty Instantaneous Wave-Free Ratio Pullback Predicts Hemodynamic Outcome In Humans With Coronary Artery Disease: Primary Results of the International Multicenter iFR GRADIENT Registry. , 2018, JACC. Cardiovascular interventions.
[21] E. Prescott,et al. The prognostic value of coronary endothelial and microvascular dysfunction in subjects with normal or non-obstructive coronary artery disease: A systematic review and meta-analysis. , 2018, International journal of cardiology.
[22] S. Plein,et al. Doppler Versus Thermodilution-Derived Coronary Microvascular Resistance to Predict Coronary Microvascular Dysfunction in Patients With Acute Myocardial Infarction or Stable Angina Pectoris , 2018, The American journal of cardiology.
[23] G. Niccoli,et al. Patients with acute myocardial infarction and non-obstructive coronary arteries: safety and prognostic relevance of invasive coronary provocative tests , 2017, European heart journal.
[24] C. Indolfi,et al. Diagnostic Performance of the Instantaneous Wave-Free Ratio: Comparison With Fractional Flow Reserve , 2018, Circulation. Cardiovascular interventions.
[25] Z. Ali,et al. Comparison of Different Diastolic Resting Indexes to iFR: Are They All Equal? , 2017, Journal of the American College of Cardiology.
[26] W. Fearon,et al. Invasive Assessment of the Coronary Microvasculature: The Index of Microcirculatory Resistance , 2017, Circulation. Cardiovascular interventions.
[27] C. Terkelsen,et al. Nonculprit Stenosis Evaluation Using Instantaneous Wave-Free Ratio in Patients With ST-Segment Elevation Myocardial Infarction. , 2017, JACC. Cardiovascular interventions.
[28] A. Jeremias,et al. Agreement of the Resting Distal to Aortic Coronary Pressure With the Instantaneous Wave-Free Ratio. , 2017, Journal of the American College of Cardiology.
[29] G. Niccoli,et al. Evaluation of intermediate coronary stenoses in acute coronary syndromes using pressure guidewire , 2017, Open Heart.
[30] Harry Hemingway,et al. Prognosis of undiagnosed chest pain: linked electronic health record cohort study , 2017, British Medical Journal.
[31] E. Omerovic,et al. Instantaneous Wave‐free Ratio versus Fractional Flow Reserve to Guide PCI , 2017, The New England journal of medicine.
[32] F. Neumann,et al. Fractional Flow Reserve‐Guided Multivessel Angioplasty in Myocardial Infarction , 2017, The New England journal of medicine.
[33] A. Jeremias,et al. Use of the Instantaneous Wave‐free Ratio or Fractional Flow Reserve in PCI , 2017, The New England journal of medicine.
[34] A. Low,et al. Invasive Assessment of the Coronary Microcirculation in Reperfused ST-Segment–Elevation Myocardial Infarction Patients: Where Do We Stand? , 2017, Circulation. Cardiovascular interventions.
[35] Jon Hainer,et al. Excess Cardiovascular Risk in Women Relative to Men Referred for Coronary Angiography Is Associated With Severely Impaired Coronary Flow Reserve, Not Obstructive Disease , 2017, Circulation.
[36] F. Crea,et al. International standardization of diagnostic criteria for vasospastic angina , 2015, European heart journal.
[37] J. Tijssen,et al. Basal stenosis resistance index derived from simultaneous pressure and flow velocity measurements. , 2016, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.
[38] K. Sakamoto,et al. Impact of Statin Therapy on Clinical Outcome in Patients With Coronary Spasm , 2016, Journal of the American Heart Association.
[39] J. Lee,et al. Combination of the Thermodilution-Derived Index of Microcirculatory Resistance and Coronary Flow Reserve Is Highly Predictive of Microvascular Obstruction on Cardiac Magnetic Resonance Imaging After ST-Segment Elevation Myocardial Infarction. , 2016, JACC. Cardiovascular interventions.
[40] G. Niccoli,et al. Coronary microvascular obstruction in acute myocardial infarction. , 2016, European heart journal.
[41] F. Crea,et al. The Who, What, Why, When, How and Where of Vasospastic Angina. , 2016, Circulation journal : official journal of the Japanese Circulation Society.
[42] Galen Cook-Wiens,et al. A randomized, placebo-controlled trial of late Na current inhibition (ranolazine) in coronary microvascular dysfunction (CMD): impact on angina and myocardial perfusion reserve , 2015, European heart journal.
[43] K. Fukuzawa,et al. Reduction in coronary microvascular resistance through cardiac resynchronization and its impact on chronic reverse remodelling of left ventricle in patients with non-ischaemic cardiomyopathy. , 2015, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.
[44] L. Køber,et al. Complete revascularisation versus treatment of the culprit lesion only in patients with ST-segment elevation myocardial infarction and multivessel disease (DANAMI-3—PRIMULTI): an open-label, randomised controlled trial , 2015, The Lancet.
[45] A. Jeremias,et al. Prospective Assessment of the Diagnostic Accuracy of Instantaneous Wave-Free Ratio to Assess Coronary Stenosis Relevance: Results of ADVISE II International, Multicenter Study (ADenosine Vasodilator Independent Stenosis Evaluation II). , 2015, JACC. Cardiovascular interventions.
[46] Ryotaro Yamada,et al. Invasive Evaluation of Patients With Angina in the Absence of Obstructive Coronary Artery Disease , 2015, Circulation.
[47] A. Curcio,et al. The instantaneous wave-free ratio (iFR) for evaluation of non-culprit lesions in patients with acute coronary syndrome and multivessel disease. , 2015, International journal of cardiology.
[48] U. Sechtem. Is FAME 2 a breakthrough for PCI in stable coronary disease? , 2014, Clinical Research in Cardiology.
[49] Manesh R. Patel,et al. Extent, location, and clinical significance of non-infarct-related coronary artery disease among patients with ST-elevation myocardial infarction. , 2014, JAMA.
[50] P. Serruys,et al. Facing the complexity of ischaemic heart disease with intracoronary pressure and flow measurements: beyond fractional flow reserve interrogation of the coronary circulation , 2014, Current opinion in cardiology.
[51] Nikola Jagic,et al. Fractional flow reserve-guided PCI for stable coronary artery disease. , 2014, The New England journal of medicine.
[52] F. Crea,et al. Coronary microvascular dysfunction in patients without myocardial diseases and obstructive atherosclerosis , 2014 .
[53] J. Kaski,et al. Clinical Usefulness, Angiographic Characteristics, and Safety Evaluation of Intracoronary Acetylcholine Provocation Testing Among 921 Consecutive White Patients With Unobstructed Coronary Arteries , 2014, Circulation.
[54] A. Jeremias,et al. Multicenter core laboratory comparison of the instantaneous wave-free ratio and resting Pd/Pa with fractional flow reserve: the RESOLVE study. , 2014, Journal of the American College of Cardiology.
[55] R. Doukky,et al. Regadenoson use in patients with chronic obstructive pulmonary disease: the state of current knowledge , 2014, International journal of chronic obstructive pulmonary disease.
[56] Nobuhiro Tanaka,et al. Functional assessment of coronary stenoses: can we live without it? , 2013, European heart journal.
[57] H. Shimokawa,et al. Clinical implications of provocation tests for coronary artery spasm: safety, arrhythmic complications, and prognostic impact: multicentre registry study of the Japanese Coronary Spasm Association. , 2013, European Heart Journal.
[58] A. Low,et al. Prognostic Value of the Index of Microcirculatory Resistance Measured After Primary Percutaneous Coronary Intervention , 2012, Circulation.
[59] Nikola Jagic,et al. Fractional flow reserve-guided PCI versus medical therapy in stable coronary disease. , 2012, The New England journal of medicine.
[60] P. Weale,et al. Microvascular Resistance Predicts Myocardial Salvage and Infarct Characteristics in ST‐Elevation Myocardial Infarction , 2012, Journal of the American Heart Association.
[61] A. Hughes,et al. Development and validation of a new adenosine-independent index of stenosis severity from coronary wave-intensity analysis: results of the ADVISE (ADenosine Vasodilator Independent Stenosis Evaluation) study. , 2012, Journal of the American College of Cardiology.
[62] P. Fitzgerald,et al. Discrepancy in the assessment of jailed side branch lesions by visual estimation and quantitative coronary angiographic analysis , 2011, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.
[63] F. Crea,et al. Contemporary Reviews in Cardiovascular Medicine Mechanisms of Coronary Artery Spasm , 2011 .
[64] K. Mizuno,et al. Effect of long-term nitrate treatment on cardiac events in patients with vasospastic angina. , 2011, Circulation journal : official journal of the Japanese Circulation Society.
[65] D. Neglia,et al. Perindopril and indapamide reverse coronary microvascular remodelling and improve flow in arterial hypertension , 2011, Journal of hypertension.
[66] William Wijns,et al. Fractional flow reserve for the assessment of nonculprit coronary artery stenoses in patients with acute myocardial infarction. , 2010, JACC. Cardiovascular interventions.
[67] H. Shimokawa,et al. Prognostic effects of calcium channel blockers in patients with vasospastic angina--a meta-analysis. , 2010, Circulation journal : official journal of the Japanese Circulation Society.
[68] C. Berry,et al. The index of microcirculatory resistance measured acutely predicts the extent and severity of myocardial infarction in patients with ST-segment elevation myocardial infarction. , 2010, JACC. Cardiovascular interventions.
[69] Ludwig Neyses,et al. Resting Pd/Pa measured with intracoronary pressure wire strongly predicts fractional flow reserve. , 2010, The Journal of invasive cardiology.
[70] U. Siebert,et al. Fractional flow reserve versus angiography for guiding percutaneous coronary intervention. , 2009, The New England journal of medicine.
[71] M. Vanderheyden,et al. Long-Term Clinical Outcome After Fractional Flow Reserve–Guided Treatment in Patients With Angiographically Equivocal Left Main Coronary Artery Stenosis , 2009, Circulation.
[72] Jeroen J. Bax,et al. Coronary microvascular resistance: methods for its quantification in humans , 2009, Basic Research in Cardiology.
[73] Carl J Pepine,et al. Adverse cardiovascular outcomes in women with nonobstructive coronary artery disease: a report from the Women's Ischemia Syndrome Evaluation Study and the St James Women Take Heart Project. , 2009, Archives of internal medicine.
[74] J. Dery,et al. Usefulness of coronary fractional flow reserve measurements in guiding clinical decisions in intermediate or equivocal left main coronary stenoses. , 2009, The American journal of cardiology.
[75] G. Heusch. Adenosine and maximum coronary vasodilation in humans: myth and misconceptions in the assessment of coronary reserve , 2009, Basic Research in Cardiology.
[76] J. Tijssen,et al. Relation between the assessment of microvascular injury by cardiovascular magnetic resonance and coronary Doppler flow velocity measurements in patients with acute anterior wall myocardial infarction. , 2008, Journal of the American College of Cardiology.
[77] Young-Seok Cho,et al. Physiological evaluation of the provisional side-branch intervention strategy for bifurcation lesions using fractional flow reserve. , 2008, European heart journal.
[78] A. Yeung,et al. Predictive value of the index of microcirculatory resistance in patients with ST-segment elevation myocardial infarction. , 2008, Journal of the American College of Cardiology.
[79] William Wijns,et al. Percutaneous coronary intervention of functionally nonsignificant stenosis: 5-year follow-up of the DEFER Study. , 2007, Journal of the American College of Cardiology.
[80] S. Carlier,et al. Coronary microvascular dysfunction after myocardial infarction: increased coronary zero flow pressure both in the infarcted and in the remote myocardium is mainly related to left ventricular filling pressure , 2007, Heart.
[81] Maria Siebes,et al. Physiological assessment of coronary artery disease in the cardiac catheterization laboratory: a scientific statement from the American Heart Association Committee on Diagnostic and Interventional Cardiac Catheterization, Council on Clinical Cardiology. , 2006, Circulation.
[82] Y. Shiratori,et al. Coronary pressure measurement to identify the lesion requiring percutaneous coronary intervention in equivocal tandem lesions , 2006, Coronary artery disease.
[83] F. Schiele,et al. One-year outcome of patients submitted to routine fractional flow reserve assessment to determine the need for angioplasty. , 2005, European heart journal.
[84] R. Hoffmann,et al. Clinical significance of fractional flow reserve for evaluation of functional lesion severity in stent restenosis and native coronary arteries. , 2005, Chest.
[85] H. Fukuda,et al. Clinical impact of selective spasm provocation tests: comparisons between acetylcholine and ergonovine in 1508 examinations , 2004, Coronary artery disease.
[86] O. Penn,et al. Percutaneous coronary intervention or bypass surgery in multivessel disease? A tailored approach based on coronary pressure measurement , 2004, Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions.
[87] J. Tijssen,et al. Short- and long-term recovery of left ventricular function predicted at the time of primary percutaneous coronary intervention in anterior myocardial infarction. , 2004, Journal of the American College of Cardiology.
[88] Maria Siebes,et al. Single-Wire Pressure and Flow Velocity Measurement to Quantify Coronary Stenosis Hemodynamics and Effects of Percutaneous Interventions , 2004, Circulation.
[89] H. Kuriyama,et al. Mechanisms of the ergonovine-induced vasoconstriction in the rabbit main coronary artery , 1984, Naunyn-Schmiedeberg's Archives of Pharmacology.
[90] H. Fukuda,et al. Induction of coronary artery spasm by two pharmacological agents: comparison between intracoronary injection of acetylcholine and ergonovine , 2003, Coronary artery disease.
[91] A. Yeung,et al. Novel Index for Invasively Assessing the Coronary Microcirculation , 2003, Circulation.
[92] F. Crea,et al. Widespread coronary inflammation in unstable angina. , 2003, The New England journal of medicine.
[93] F. N. van de Vosse,et al. Coronary Thermodilution to Assess Flow Reserve: Validation in Humans , 2002, Circulation.
[94] G. Heyndrickx,et al. Coronary Thermodilution to Assess Flow Reserve: Experimental Validation , 2001, Circulation.
[95] H. Figulla,et al. Microvascular Dysfunction in Chronic Total Coronary Occlusions , 2001, Circulation.
[96] N. Ochi,et al. Major complications during spasm provocation tests with an intracoronary injection of acetylcholine. , 2000, The American journal of cardiology.
[97] S. Reis,et al. Coronary flow velocity response to adenosine characterizes coronary microvascular function in women with chest pain and no obstructive coronary disease. Results from the pilot phase of the Women's Ischemia Syndrome Evaluation (WISE) study. , 1999, Journal of the American College of Cardiology.
[98] Chang Mau-Song,et al. Effects of short-term treatment of nicorandil on exercise-induced myocardial ischemia and abnormal cardiac autonomic activity in microvascular angina , 1997 .
[99] B. De Bruyne,et al. Clinical assessment of functional stenosis severity: use of coronary pressure measurements for the decision to bypass a lesion. , 1997, The Annals of thoracic surgery.
[100] P. H. van der Voort,et al. Measurement of fractional flow reserve to assess the functional severity of coronary-artery stenoses. , 1996, The New England journal of medicine.
[101] O. Hess,et al. Effect of diltiazem on coronary flow reserve in patients with microvascular angina. , 1995, International journal of cardiology.
[102] H. M. Payne,et al. Validation of A Doppler Guide Wire for Intravascular Measurement of Coronary Artery Flow Velocity , 1992, Circulation.
[103] K. Okumura,et al. Sensitivity and specificity of intracoronary injection of acetylcholine for the induction of coronary artery spasm. , 1988, Journal of the American College of Cardiology.
[104] S. Chierchia,et al. Induction of coronary artery spasm by a direct local action of ergonovine. , 1987, Circulation.
[105] J. Hodgson,et al. Prediction of long-term clinical outcome with final translesional pressure gradient during coronary angioplasty. , 1986, Circulation.
[106] W. Vaughn,et al. Exacerbation of Vasotonic Angina Pectoris by Propranolol , 1982, Circulation.
[107] W. Siegenthaler,et al. Nonoperative dilatation of coronary-artery stenosis: percutaneous transluminal coronary angioplasty. , 1979, The New England journal of medicine.
[108] K. Lipscomb,et al. Effects of coronary stenoses on coronary flow reserve and resistance. , 1974, The American journal of cardiology.